stars 1 stars 2 stars 3

GeniPhys was founded on the vision that biomaterials should support functional tissue restoration, not simply be tolerated or rapidly degrade. Collymer is a proprietary collagen polymer designed to preserve natural biological and structural features of collagen while offering design flexibility and manufacturability of sythetic polymers. Collymer Self-Assembling Scaffold (Collymer SAS) is GeniPhys first product. It is an in-situ forming scaffold that flows into and conforms to complex wounds, then rapidly forms a stable collagen fibril matrix. Collymer SAS is FDA 510(k) cleared and poised for commercial launch and clinical impact. Beyond wound care, Collymer represents a customizable platform biomaterial with a myriad of potential clinical applications where its pardigm-shifting mechanism of action could drive improved patient outcomes.

GeniPhys, Inc. Questions

The GeniPhys, Inc. annual revenue was $4.8 million in 2026.

Andy Eibling is the President and CEO of GeniPhys, Inc..

4 people are employed at GeniPhys, Inc..

GeniPhys, Inc. is based in Indianapolis, Indiana.

The NAICS codes for GeniPhys, Inc. are [54, 541].

The SIC codes for GeniPhys, Inc. are [87, 873].

Top GeniPhys, Inc. Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users